These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9452994)

  • 41. Screening for CLCN5 mutation in renal calcium stone formers patients.
    Rebelo MA; Tostes V; Araújo NC; Martini SV; Botelho BF; Guggino WB; Morales MM
    An Acad Bras Cienc; 2005 Mar; 77(1):95-101. PubMed ID: 15692680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hereditary kidney tubular diseases].
    Sasaki S
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():107-11. PubMed ID: 17899836
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical features of X-linked nephrolithiasis in childhood.
    Langlois V; Bernard C; Scheinman SJ; Thakker RV; Cox JP; Goodyer PR
    Pediatr Nephrol; 1998 Oct; 12(8):625-9. PubMed ID: 9811383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies.
    Scheinman SJ; Pook MA; Wooding C; Pang JT; Frymoyer PA; Thakker RV
    J Clin Invest; 1993 Jun; 91(6):2351-7. PubMed ID: 8099916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis).
    Fisher SE; Black GC; Lloyd SE; Hatchwell E; Wrong O; Thakker RV; Craig IW
    Hum Mol Genet; 1994 Nov; 3(11):2053-9. PubMed ID: 7874126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of novel promoter and enhancer elements of the mouse homologue of the Dent disease gene, CLCN5, implicated in X-linked hereditary nephrolithiasis.
    Tanaka K; Fisher SE; Craig IW
    Genomics; 1999 Jun; 58(3):281-92. PubMed ID: 10373326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The genetic basis of X-linked nephrolithiasis: leaving no stone unturned.
    Shapiro LJ
    J Clin Invest; 1993 Jun; 91(6):2339. PubMed ID: 8514847
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathogenesis of hypercalciuric nephrolithiasis.
    Zerwekh JE; Reed-Gitomer BY; Pak CY
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):869-84. PubMed ID: 12474635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.
    Wrong OM; Norden AG; Feest TG
    QJM; 1994 Aug; 87(8):473-93. PubMed ID: 7922301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chloride channels and endocytosis: new insights from Dent's disease and CLC-5 knockout mice.
    Devuyst O
    Bull Mem Acad R Med Belg; 2004; 159(Pt 2):212-7. PubMed ID: 15615095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular physiology of renal chloride channels.
    Steinmeyer K; Jentsch TJ
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):497-502. PubMed ID: 9818195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The calcium-activated chloride channel Anoctamin 1 contributes to the regulation of renal function.
    Faria D; Rock JR; Romao AM; Schweda F; Bandulik S; Witzgall R; Schlatter E; Heitzmann D; Pavenstädt H; Herrmann E; Kunzelmann K; Schreiber R
    Kidney Int; 2014 Jun; 85(6):1369-81. PubMed ID: 24476694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stones, bones, and heredity.
    Milliner DS
    Acta Paediatr Suppl; 2006 Jul; 95(452):27-30. PubMed ID: 16801162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
    He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
    J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role and function of voltage-gated chloride channels of the CIC family and their defects leading to genetic diseases].
    Dołowy K; Bednarczyk P; Hordejuk R; Dworakowska B; Nurowska E; Jarzabek W
    Postepy Hig Med Dosw; 2002; 56(3):307-13. PubMed ID: 12194243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in understanding the clinical and genetic heterogeneity of Dent's disease.
    Ludwig M; Utsch B; Monnens LA
    Nephrol Dial Transplant; 2006 Oct; 21(10):2708-17. PubMed ID: 16861240
    [No Abstract]   [Full Text] [Related]  

  • 57. ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.
    Piwon N; Günther W; Schwake M; Bösl MR; Jentsch TJ
    Nature; 2000 Nov; 408(6810):369-73. PubMed ID: 11099045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unravelling of the molecular mechanisms of kidney stones. Report of a Meeting of Physicians and Scientists.
    Lancet; 1996 Dec; 348(9041):1561-5. PubMed ID: 8950885
    [No Abstract]   [Full Text] [Related]  

  • 59. Dent disease with compound heterozygous mutations leading to severe chronic renal failure in a female patient.
    Holder M; Bald M; Leichter HE; Ludwig M
    Pediatr Nephrol; 2004 Jan; 19(1):122; author reply 123. PubMed ID: 14648329
    [No Abstract]   [Full Text] [Related]  

  • 60. Inherited proximal tubular disorders and nephrolithiasis.
    Oliveira B; Unwin R; Walsh SB
    Urolithiasis; 2019 Feb; 47(1):35-42. PubMed ID: 30673801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.